High Prevalence of Epstein Barr Virus and Other Viral Markers Found in Patients with Chronic Fatigue Syndrome
Nikhil Prasad Fact checked by:Thailand Medical News Team Mar 14, 2025 5 hours, 34 minutes ago
Medical News: Scientists Investigate Viral Link to Chronic Fatigue Syndrome
A recent study by researchers from Linköping University and Umeå University in Sweden has revealed a strong connection between chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME), and the presence of Epstein-Barr virus (EBV) in sputum samples. The study examined the viral load of several viruses in ME/CFS patients compared to healthy individuals and other control groups, shedding light on potential underlying causes of this debilitating condition.
High Prevalence of Epstein Barr Virus and Other Viral Markers Found in Patients with Chronic Fatigue Syndrome
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a chronic and complex disorder affecting millions worldwide. Patients experience extreme fatigue, cognitive issues, and immune dysfunctions that severely impact daily life. Despite ongoing research, the exact causes of ME/CFS remain unclear. However, infections, particularly viral infections, have long been suspected as a possible trigger. This
Medical News report highlights a new study that adds further evidence to this hypothesis.
Key Findings of the Study
The research team analyzed sputum samples from 29 participants, including 13 ME/CFS patients, 10 healthy controls, 4 elderly controls, and 2 immunosuppressed individuals. The focus was on detecting five viruses: Epstein-Barr virus (EBV), human herpesvirus 6 (HHV-6), human cytomegalovirus (HCMV), human adenovirus (HAdV), and SARS-CoV-2. Additionally, the study examined the presence of autoantibodies to type I interferon (IFN-I), which play a role in the immune response.
The most striking finding was that 85% of ME/CFS patients had EBV present in their sputum, compared to only 50% of the healthy control group. The viral load of EBV in ME/CFS patients was significantly higher, indicating that these individuals might struggle to control the virus effectively. HHV-6 was detected in nearly 50% of all participants, regardless of health status, while HAdV appeared in two individuals: one severely affected ME/CFS patient and one immunosuppressed control. Meanwhile, HCMV and SARS-CoV-2 were only found in the immunosuppressed group.
The study also looked at autoantibodies to type I interferon, which could indicate an impaired immune response. Interestingly, while most ME/CFS patients showed similar levels of these autoantibodies as the healthy controls, one severely affected patient had elevated levels. This suggests that in severe cases, the immune system's ability to fight off viral infections may be further compromised.
What These Findings Mean
The presence of high EBV levels in ME/CFS patients strengthens the argument that viral infections play a significant role in the disease. Epstein-Barr virus is known to establish lifelong infection in humans and can reactivate under conditions of immune dysfunction. The results suggest that ME/CFS patients may have an impaired ability to keep EBV under control, leading to chron
ic activation that could contribute to their symptoms.
The fact that HHV-6 was detected in a similar proportion across all groups indicates that it may not be a distinguishing factor in ME/CFS. However, the presence of HAdV in a severely affected ME/CFS patient raises the possibility that certain viruses may play a role in worsening symptoms in more extreme cases. Further research is needed to determine whether adenovirus has a unique connection to severe ME/CFS.
The findings regarding autoantibodies to type I interferon suggest that, for most ME/CFS patients, this specific immune dysfunction is not a primary issue. However, the exception of one severe case means that further investigations are needed to understand whether a subset of ME/CFS patients might have a different immune response.
The Need for Further Research and Treatment Exploration
This study provides strong evidence that ME/CFS patients have a higher burden of EBV in their respiratory system, which could be contributing to their symptoms. However, the exact mechanisms behind this relationship remain unknown. Do ME/CFS patients struggle to clear EBV due to a weakened immune response, or does EBV itself drive the disease process? Answering these questions will be critical in developing targeted treatments.
Antiviral therapies could be a potential avenue for treating ME/CFS, particularly for those with high EBV viral loads. Certain antiviral drugs, such as Brincidofovir, have been shown to be effective against various herpesviruses, including EBV and HHV-6. Clinical trials testing antiviral medications in ME/CFS patients would help determine whether reducing viral load improves symptoms.
Another area for further study is the role of immune modulation. If ME/CFS is partly caused by an inability to regulate viral infections, therapies that strengthen or balance the immune system might be beneficial. More research into autoantibodies and other immune markers could provide new insights into how the immune system behaves in ME/CFS patients.
Conclusion
This study highlights a significant association between Epstein-Barr virus and ME/CFS, adding to the growing body of evidence that viral infections may play a key role in the disease. While more research is needed to fully understand the mechanisms, these findings open the door to potential new treatments, including antiviral and immune-modulating therapies. For ME/CFS patients who have long struggled with a lack of clear answers, these results provide hope that science is moving closer to uncovering the true causes of their condition.
The study findings were published on a preprint server and is currently being peer reviewed.
https://www.preprints.org/manuscript/202502.0185/v3
For the latest on Chronic Fatigue Syndrome, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/news/comparisons-of-fatigue-intensity-in-post-covid-condition-fibromyalgia-and-multiple-sclerosis
https://www.thailandmedical.news/news/traditional-japanese-medicine-hochuekkito-shows-promise-in-treating-fatigue-in-long-covid-patients
https://www.thailandmedical.news/news/brain-changes-linked-to-long-covid-and-chronic-fatigue-explored-in-new-australian-study
https://www.thailandmedical.news/pages/thailand_doctors_listings
Follow us on:
https://x.com/ThailandMedicaX
https://www.facebook.com/ThailandMedicalNews
https://bsky.app/profile/thailandmedical.bsky.social
https://gettr.com/user/thailandmedicalnews
https://www.tribel.com/thailandmedical/wall
and 33 other social media platforms
Share
Tweet
Share
